AbbVie Inc.

Healthcare

NYSE:ABBV · New York Stock Exchange

Market Cap $401.40B Beta 0.31 P/E (TTM) 110.7

$227.19 +1.08%

+$2.42 today

52W Low $181.73High $244.81

Vol 2.08M · Avg 6.53M

EPS (TTM)$2.05

Div Yield2.97%

Drug Manufacturers - General

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+21.93%

Period High

$238.72

Period Low

$176.56

Latest

$227.21

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Johnson & Johnson

NYSE:JNJ

$578.11B

UnitedHealth Group Incorporated

NYSE:UNH

$370.46B

Merck & Co., Inc.

NYSE:MRK

$296.38B

Novartis AG

NYSE:NVS

$292.82B

AstraZeneca PLC

NYSE:AZN

$278.78B

Novo Nordisk A/S

NYSE:NVO

$196.35B

Amgen Inc.

NASDAQ:AMGN

$191.18B

Gilead Sciences, Inc.

NASDAQ:GILD

$155.63B

Pfizer Inc.

NYSE:PFE

$149.30B

Sanofi

NASDAQ:SNY

$106.49B

What is the latest ABBV filing?

The latest filing shown is SD dated Jun 1, 2026.

How many recent filings does ABBV have?

Intrinsic Alpha currently shows 20 recent filings for ABBV.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.